Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary research question is to confirm the feasibility and efficacy of using a combination of Gemcitabine and Bexarotene for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have disease that is no longer controlled by skin-directed therapy and who have had at least one prior systemic therapy.
Critère d'inclusion
- Relapsed/refractory cutaneous T-cell lymphoma